About WoundlyClinical
WoundlyClinical was a Healthcare company based in Pune (India) founded in 2019 by Atul Aslekar and Supreet Deshpande. It offers an app for monitoring and managing wound healing progression. It operates on a B2B model. Its chief executive is Supreet Deshpande. Its Indian entity Novalead Pharma Private Limited reported revenue of ₹16.4 Lakh. The company is recorded as dissolved. Its focus areas include Health Tech, Healthcare Software, Wound Care and Monitoring Apps. Its competitors include Swift Medical, cureVision, MedInnoScan, WUNDERA and WoundAssure and 2 more; 2 of its 7 listed competitors have raised funding.
Company details
WoundlyClinical, established in 2019, excels in health tech, healthcare software, wound care, and monitoring apps. Offers an app for monitoring and managing wound healing progression. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Pune, India
- Founders Atul Aslekar, Supreet Deshpande
- SectorsHealthcare
- Website woundlyclinical.com
- Legal Name Novalead Pharma Private Limited
- Date of Incorporation 31 Oct, 2007
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹16.4 Lakh
FY 2024 · -97% YoY
- Net Loss-₹3.53 Cr
FY 2024 · -2153% margin
- EBITDA-₹3.13 Cr
FY 2024 · -1907% margin
Associated legal entities of WoundlyClinical
WoundlyClinical operates through Novalead Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novalead Pharma Private Limited CIN U73100PN2007PTC130929 | Active | 31 Oct 2007 | Pune, Maharashtra | ₹0.2 Cr | – | 6 | View details |
Board of directors of Novalead Pharma Private Limited (WoundlyClinical)
Novalead Pharma Private Limited is the primary company behind WoundlyClinical. The board of Novalead Pharma Private Limited currently have 6 directors; the longest-serving is Atul Sharad Aslekar, appointed in 2007. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Atul Sharad Aslekar DIN 00126698 | Director | 31 Oct 2007 | 18 yrs 11 mo | Novalead Pharma Private Limited |
| Supreet Deshpande Kiran DIN 00126671 | Director | 31 Oct 2007 | 18 yrs 11 mo | Novalead Pharma Private Limited |
| Sudhir Kulkarni Appaji DIN 02768943 | Director | 17 Aug 2009 | 17 yrs 2 mo | Novalead Pharma Private Limited |
| Girish Vithalrao Lakhe DIN 00335011 | Director | 17 Aug 2009 | 17 yrs 2 mo | Novalead Pharma Private Limited |
| Sankara Narayanan Sankarasubramanian DIN 03543495 | Nominee Director | 24 Nov 2022 | 3 yrs 10 mo | Novalead Pharma Private Limited |
| Vandan Girdharlal Agrawal DIN 00041252 | Nominee Director | 24 Nov 2022 | 3 yrs 10 mo | Novalead Pharma Private Limited |
People of WoundlyClinical
2 people are tracked at WoundlyClinical (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Founder, CEO | Leadership |
Complete people profiles for WoundlyClinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of WoundlyClinical
Figures of Novalead Pharma Private Limited, the primary company behind WoundlyClinical, for FY 2024. Revenue was ₹16.4 Lakh (-97% year on year). Net loss was -₹3.53 Cr (-2153% margin). EBITDA was -₹3.13 Cr (-1907% margin). Revenue has grown at a compounded annual rate of -49% over three years and -38% over five years.
- ₹16.4 LakhRevenue · FY 2024 · -97% YoY
- -₹3.53 CrNet loss · -2153% margin
- -₹3.13 CrEBITDA · -1907% margin
- ₹1.8 LakhPaid-up capital
- -49%Revenue CAGR, 3 years
- -38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Novalead Pharma Private Limited are on its company page.
Detailed financial statements for WoundlyClinical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of WoundlyClinical
WoundlyClinical has 7 listed competitors in our database, 2 of them funded. They include Swift Medical, cureVision, MedInnoScan, WUNDERA and WoundAssure, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| swiftmedical.com | 2015 | Toronto, Canada | $48M | – | AI-based wound care and diagnosis tool | |
| curevision.de | 2020 | Munich, Germany | $100,000 | – | Automatic wound analysis platform is provided for chronic care assessment. | |
| medinnoscan.com | 2017 | Budapest, Hungary | – | – | AI-based chronic wound diagnosis software is provided to healthcare providers. | |
| wundera.health | 2019 | Leipzig, Germany | – | – | Provider of AI-based wound diagnosis and documentation app for healthcare providers | |
| woundassure.com | 2019 | Los Angeles, United States | – | – | Delivers hardware-based care solutions for healthcare systems. | |
| woundheal-analytics.com | 2018 | Bengaluru, India | – | – | AI-driven app for analyzing and monitoring wound healing processes via smartphones. | |
| megaperceptron.com | 2020 | Milwaukee, United States | – | – | Offers AI-based wound analysis software for healthcare providers and patients. |
Detailed competitors of WoundlyClinical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Health Monitoring & Wearables
10 companies that operate in the same segment as WoundlyClinical (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | USD 398.5 M | 1,632 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | USD 275.25 M | 701 | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Woundlyclinical
Complete news archive for WoundlyClinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WoundlyClinical
WoundlyClinical was founded in 2019.
WoundlyClinical is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Supreet Deshpande is the current CEO of WoundlyClinical. They have also founded this company.
The primary company behind WoundlyClinical, Novalead Pharma Private Limited, reported revenue of ₹16.4 Lakh for FY 2024, down 97% year on year.
WoundlyClinical, established in 2019, excels in health tech, healthcare software, wound care, and monitoring apps. Offers an app for monitoring and managing wound healing progression. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
WoundlyClinical's top competitors include Swift Medical, cureVision and WUNDERA.
WoundlyClinical operates through Novalead Pharma Private Limited.
The legal entities of WoundlyClinical currently have 6 directors, including Sankara Narayanan Sankarasubramanian, Sudhir Kulkarni Appaji, Vandan Girdharlal Agrawal and others.